Home > Insider Trading > Filing (0001140361-18-028126)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581720	Loxo Oncology Inc.	LOXO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242613	M Timothy Mayleben	C/O Loxo Oncology, Inc. 281 Tresser Blvd, 9Th Floor Stamford CT 06901		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-06-08	7,416	$20.91	7,416	No	4	M	Direct
Common Stock	Acquisiton	2018-06-08	2,584	$24.18	10,000	No	4	M	Direct
Common Stock	Disposition	2018-06-08	10,000	$179.55	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director Stock Option (right to buy)	Disposition	2018-06-08	7,416	$0.00	7,416	$20.91
Common Stock	Director Stock Option (right to buy)	Disposition	2018-06-08	2,584	$0.00	2,584	$24.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,209		2025-07-27	No	4	M	Direct
5,228		2026-06-09	No	4	M	Direct

Footnotes

Represents the aggregate of sales effected on the same day at different prices.
Represents the weighted average sales price per share. The shares sold at prices ranging from $179.00 to $180.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
The stock option vests and becomes exercisable as to 1/3 of the shares subject to the option on the one-year anniversary of the grant date, and thereafter vests as to an additional 1/3 of the shares annually.
The stock option is fully vested and immediately exercisable.